CalvinC.ShengMD
Cardiology • Cleveland, OHInterventional Cardiology, Peripheral Endovascular Interventional Cardiology
Interventional Cardiology Fellow
Dr. Sheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 EUCLID AVENUE/NA-23
J3-129
Cleveland, OH 44195Fax+1 844-313-9344- Is this information wrong?
Summary
- Dr. Calvin Sheng is a cardiologist in Cleveland, OH and is affiliated with Cleveland Clinic. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 6 years. He also speaks multiple languages, including Chinese (Mandarin). He specializes in interventional cardiology, structural cardiology, CHIP, and peripheral endovascular interventions. He has more than 10 publications and over 500 citings.
Education & Training
Cleveland Clinic FoundationFellowship, Interventional Cardiology, 2022 - 2024- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2019 - 2022
Johns Hopkins UniversityResidency, Internal Medicine, 2016 - 2019
Vanderbilt University School of MedicineClass of 2016, MD, AOA
Duke UniversityBS, Biology, Magna Cum Laude, PKB, 2007 - 2011
Certifications & Licensure
OH State Medical License 2019 - 2026
MD State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
- Certification Board of Nuclear Cardiology (CBNC)American Society of Nuclear Cardiology (ASNC)
- National Board of Echocardiography (NBE)American Society of Echocardiography (ASE)
- Registered Physician in Vascular Interpretations (RPVI)The Alliance for Physician Certification & Advancement (APCA)
Awards, Honors, & Recognition
- Alpha Omega Alpha 2016
- Sarnoff Cardiovascular Research Fellowship 2014-2015
- Phi Kappa Beta 2011
- Join now to see all
Clinical Trials
- Canakinumab in Covid-19 Cardiac Injury (The Three C Study) Start of enrollment: 2020 Apr 24
- Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation Start of enrollment: 2020 May 20
Publications & Presentations
PubMed
- Images in Vascular Medicine: Valsalva purpura secondary to balloon occlusion of the cavoatrial junction during intervention for lead-induced SVC syndrome.Calvin C Sheng, Bruce L Wilkoff, Sean P Lyden, Edward Soltesz, Scott J Cameron, Aravinda Nanjundappa> ;Vascular Medicine. 2023 Oct 1
- Successful Endovascular Treatment of an Anastomotic Pseudoaneurysm in the Ascending Aorta.Calvin Chen Sheng, Adrian Santini, Frank H Annie, Muhammad Rawala, Deepak L Bhatt, Aravinda Nanjundappa> ;The American Journal of Cardiology. 2023 Sep 15
- 2 citationsImpaired Reorganization of Centrosome Structure Underlies Human Infantile Dilated Cardiomyopathy.Young Wook Chun, Matthew Miyamoto, Charles H Williams, Leif R Neitzel, Maya Silver-Isenstadt, Adrian G Cadar, Daniela T Fuller, Daniel C Fong, Hanhan Liu, Robert Lease...> ;Circulation. 2023 Apr 25
- Join now to see all
Journal Articles
- 21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized MedicineSheng, C.C., L. Amiri-Kordestani, T. Palmby, T. Force, C.C. Hong, J. C. Wu, G. Kim, & J. Moslehi, JACC-BTS
Other Languages
- Chinese (Mandarin)
Hospital Affiliations
Cleveland ClinicCleveland, Ohio
External Links
- LinkedInhttps://www.linkedin.com/in/calvin-sheng-78622568/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
